Cargando…

Evoked Potentials and Neuropsychological Tests Validate Positron Emission Topography (PET) Brain Metabolism in Cognitively Impaired Patients

Fluorodeoxyglucose (FDG) Positron Emission Topography (PET) brain hypometabolism (HM) correlates with diminished cognitive capacity and risk of developing dementia. However, because clinical utility of PET is limited by cost, we sought to determine whether a less costly electrophysiological measure,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braverman, Eric R., Blum, Kenneth, Damle, Uma J., Kerner, Mallory, Dushaj, Kristina, Oscar-Berman, Marlene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604004/ https://www.ncbi.nlm.nih.gov/pubmed/23526928 http://dx.doi.org/10.1371/journal.pone.0055398

Ejemplares similares

Preliminary Hormonal Correlations in Female Patients as a Function of Somatic and Neurological Symptom Clusters: An Exploratory Development of a Multi-Hormonal Map for Bio-Identical Replacement Therapy (MHRT)
por: Braverman, Eric R, et al.
Publicado: (2013)

Test of variables of attention (TOVA) as a predictor of early attention complaints, an antecedent to dementia
por: Braverman, Eric R, et al.
Publicado: (2010)

Menopause Analytical Hormonal Correlate Outcome Study (MAHCOS) and the Association to Brain Electrophysiology (P300) in a Clinical Setting
por: Braverman, Eric R., et al.
Publicado: (2014)

Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients
por: Braverman, Eric R., et al.
Publicado: (2015)

Adult growth hormone deficiency treatment with a combination of growth hormone and insulin-like growth factor-1 resulting in elevated sustainable insulin-like growth factor-1 and insulin-like growth factor binding protein 3 plasma levels: a case report
por: Braverman, Eric R, et al.
Publicado: (2010)

A Multi-Locus Approach to Treating Fibromyalgia by Boosting Dopaminergic Activity in the Meso-Limbic System of the Brain
por: Blum, Kenneth, et al.
Publicado: (2014)

Positron Emission Tomography (PET) in Oncology
por: Gallamini, Andrea, et al.
Publicado: (2014)

NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity
por: Schoenthaler, Stephen J., et al.
Publicado: (2015)

Obsessive Compulsive Disorder Networks: Positron Emission Tomography and Neuropsychology Provide New Insights
por: Millet, Bruno, et al.
Publicado: (2013)

Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward
por: Blum, Kenneth, et al.
Publicado: (2015)

Insulinoma - The incremental value of somatostatin receptor positron emission tomography
por: Arunraj, S. T., et al.
Publicado: (2017)

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019)

Hypothesizing that, A Pro-Dopamine Regulator (KB220Z) Should Optimize, but Not Hyper-Activate the Activity of Trace Amine-Associated Receptor 1 (TAAR-1) and Induce Anti-Craving of Psychostimulants in the Long-Term
por: Blum, Kenneth, et al.
Publicado: (2016)

The Topography of Striatal Dopamine and Symptoms in Psychosis: An Integrative Positron Emission Tomography and Magnetic Resonance Imaging Study
por: McCutcheon, Robert A., et al.
Publicado: (2020)

Posterior cortical atrophy: correlation between clinical, neuropsychological, magnetic resonance and positron emission tomography Imaging
por: Chabrashvili, Tinatin, et al.
Publicado: (2013)

Brain volumes and neuropsychological performance are related to current smoking and alcoholism history
por: Luhar, Riya B, et al.
Publicado: (2013)

Pro-Dopamine Regulator – (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS)
por: Blum, Kenneth, et al.
Publicado: (2017)

Myelin positron emission tomography (PET) imaging in multiple sclerosis
por: de Paula Faria, Daniele
Publicado: (2020)

Fluorinated carbohydrates for (18)F-positron emission tomography (PET)
por: Campbell, Emma, et al.
Publicado: (2023)

RF11 | PSAT370 I-PET Score: Combining Whole Body Iodine Scan and 18 Fluorodeoxyglucose Positron Emission Topography to Predict Progression in Thyroid Cancer
por: Wijewardene, Ayanthi, et al.
Publicado: (2022)

Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction
por: Blum, Kenneth, et al.
Publicado: (2015)

Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability
por: Bowirrat, Abdalla, et al.
Publicado: (2010)

Age-related increases in parathyroid hormone may be antecedent to both osteoporosis and dementia
por: Braverman, Eric R, et al.
Publicado: (2009)

Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients
por: Zinzani, P L, et al.
Publicado: (2004)

State of the art of Positron Emission Tomography (PET) technology and current challenges
por: Conti, Maurizio
Publicado: (2021)

The AX-PET experiment: A demonstrator for an axial Positron Emission Tomograph
por: Bolle, E, et al.
Publicado: (2013)

KB220Z™ a Pro-Dopamine Regulator Associated with the Protracted, Alleviation of Terrifying Lucid Dreams. Can We Infer Neuroplasticity-induced Changes in the Reward Circuit?
por: McLaughlin, Thomas, et al.
Publicado: (2016)

Scalp Topography of Lower Urinary Tract Sensory Evoked Potentials
por: van der Lely, Stéphanie, et al.
Publicado: (2020)

Multiple Lytic Lesions on F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography not Always Metastatic?
por: Passah, Averilicia, et al.
Publicado: (2018)

Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary
por: Blum, Kenneth, et al.
Publicado: (2008)

Measurement of Striatal Dopamine Release Induced by Neuropsychological Stimulation in Positron Emission Tomography With Dual Injections of [(11)C]Raclopride
por: Ikoma, Yoko, et al.
Publicado: (2022)

Graves' Ophthalmopathy on (68)Ga-DOTANOC Positron Emission Tomography/Computed Tomography
por: Arora, Saurabh, et al.
Publicado: (2019)

(18)F-Fludeoxyglucose Positron-emission Tomography/Computed Tomography in Encephalocraniocutaneous Lipomatosis/Haberland Syndrome
por: Tripathy, Sarthak, et al.
Publicado: (2019)

Preliminary investigation of plasma levels of sex hormones and human growth factor(s), and P300 latency as correlates to cognitive decline as a function of gender
por: Braverman, Eric R, et al.
Publicado: (2009)

Coupling Genetic Addiction Risk Score (GARS) with Electrotherapy: Fighting Iatrogenic Opioid Dependence
por: Blum, Kenneth, et al.
Publicado: (2013)

Trackable and Targeted Phage as Positron Emission Tomography (PET) Agent for Cancer Imaging
por: Li, Zibo, et al.
Publicado: (2011)

Photo-Detectors for Time of Flight Positron Emission Tomography (ToF-PET)
por: Spanoudaki, Virginia Ch., et al.
Publicado: (2010)

Positron emission tomography (PET) in primary prostate cancer staging and risk assessment
por: Bednarova, Sandra, et al.
Publicado: (2017)

Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia
por: Ricci, Maria, et al.
Publicado: (2020)

PET-BIDS, an extension to the brain imaging data structure for positron emission tomography
por: Norgaard, Martin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qfgfd9ouoaf3sfgckle8q5taps